title: [Infliximab and amyloidosis secondary to inflammatory bowel diseases].
authors.forename: José Luis
authors.initials: JL
authors.lastname: Callejas Rubio
authors.forename: Norberto
authors.initials: N
authors.lastname: Ortego Centeno
authors.forename: Carlos
authors.initials: C
authors.lastname: Cárdeña Pérez
authors.forename: Antonio
authors.initials: A
authors.lastname: Navas-Parejo
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000188:drug therapy* / Q000209:etiology*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D007674:Kidney Diseases / Q000188:drug therapy / Q000209:etiology; D014409:Tumor Necrosis Factor-alpha
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab